One would like to think that this will involve positive news. At least the market pre-open seems to like the potential..PR Newswire - Thursday, August 31, 2000
MONTREAL, Aug. 31 /CNW-PRN/ - Dr. Francois Martin, Senior Vice-President, Scientific Affairs, Axcan Pharma Inc., invites you to take part in a conference call to discuss new developments related to the Company's recently acquired Photofrin(R) therapy for the treatment of cancer and cancer related diseases such as Barrett's esophagus.
Dr. Martin will be accompanied by Dr. Patrick Colin, Axcan's Vice-President, Cinical Research, and by Mr. Patrick McLean, Vice-President and General Manager, Canada and Europe, who will also be available to answer your questions.
Tuesday, September 5, 2000, at 11:00 A.M.
Please dial the following toll-free number:
1 - 800-478 - 9326
It will be possible for you to follow the conference call on the Internet using the following address : www.axcan.com.
You will also be able to listen to the presentations made during the conference call for a period of 90 days following the call.
xxx |
